Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a simple patch make stomach cancer surgery safer?

NCT ID NCT06464978

First seen Apr 14, 2026 · Last updated Jun 22, 2026 · Updated 10 times

Summary

This study compares using a reinforcement patch on surgical staplers versus standard staplers during stomach surgery (gastrojejunostomy) for gastric cancer. The goal is to see if the patch lowers the risk of leaks, bleeding, or narrowing at the connection site. About 382 patients will take part across multiple hospitals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Yunhong Tian

    RECRUITING

    Nanchong, Sichuan, 637000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

stapler reinforcement patch (device)

What this could lead to

If it works, this could reduce serious complications like leaks after stomach surgery, making recovery safer for gastric cancer patients.

What could go wrong

This is a device comparison, not a new drug or cure. The benefit may be small, and results may not apply to all surgery types or hospitals.

Conditions

The condition(s) this trial relates to.

Anastomotic Leak gastric neoplasm Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.